Investor Overview Press Releases November 12, 2026 Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference November 5, 2026 Aclaris Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate and Clinical Update October 27, 2026 Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants View all » Events Nov 16, 202610:30 AM GMT Jefferies Global Healthcare Conference Oct 27, 20268:00 AM EDT ATI-052 Phase 1b POC Results Update Sep 10, 20262:45 PM EDT 2026 Cantor Global Healthcare Conference View all » Feature Presentation August 2026 Corporate Presentation
November 5, 2026 Aclaris Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate and Clinical Update
October 27, 2026 Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants
